| IRCZX | QISRX | IRCZX / QISRX | |
| Total Expense Ratio | 1.10 | 0.96 | 115% |
| Annual Report Gross Expense Ratio | 1.10 | 1.13 | 97% |
| Fund Existence | 11 years | 8 years | - |
| Gain YTD | 10.198 | 14.664 | 70% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 100000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.26B | 59.9M | 2,107% |
| Annual Yield % from dividends | 2.15 | 1.59 | 135% |
| Returns for 1 year | 3.67 | 15.14 | 24% |
| Returns for 3 years | 41.24 | 32.72 | 126% |
| Returns for 5 years | 23.14 | 12.37 | 187% |
| Returns for 10 years | 69.30 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ZEMIX | 15.37 | 0.16 | +1.05% |
| American Beacon Ninety One Emr Mkts EqR5 | |||
| NSVAX | 15.78 | N/A | N/A |
| Columbia Sm Cp Val and Inflection Inst | |||
| GQEIX | 21.27 | N/A | N/A |
| GQG Partners US Select Quality Eq Instl | |||
| WFPCX | 45.34 | N/A | N/A |
| Allspring Special Mid Cap Value C | |||
| IGFSX | 6.92 | N/A | N/A |
| VY® Morgan Stanley Global Franchise S2 | |||